Metraipolis › archive › dc_b36cb95077ac
Reverse-Engineered Lipid Nanoparticles Harness Protein Corona Formation for Cytokine Sequestration and Combination Immunomodulatory Therapy — Europe PMC PMID:42522898
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42522898
- DOI
- 10.1002/smll.74914
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-17T10:50:32.942Z
- SHA-256 of the archived text
e7585c57e673266f1bee10f165d90255367789252f4d2471306179e82c476d10- Stable URL of this page
https://metraipolis.com/documento/dc_b36cb95077ac
How to cite
Reverse-Engineered Lipid Nanoparticles Harness Protein Corona Formation for Cytokine Sequestration and Combination Immunomodulatory Therapy — Europe PMC PMID:42522898 — Europe PMC (en), https://europepmc.org/article/MED/42522898 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_b36cb95077ac (Metraipolis archive dc_b36cb95077ac, sha256 e7585c57e673266f1bee10f165d90255367789252f4d2471306179e82c476d10)
BibTeX
@misc{dcb36cb95077ac,
title = {Reverse-Engineered Lipid Nanoparticles Harness Protein Corona Formation for Cytokine Sequestration and Combination Immunomodulatory Therapy — Europe PMC PMID:42522898},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42522898},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_b36cb95077ac; sha256 e7585c57e673266f1bee10f165d90255367789252f4d2471306179e82c476d10},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42522898. Agents can read the archived copy with the MCP tool read_document.